Ardelyx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.About ARDX
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines.
CEOMichael G. Raab
CEOMichael G. Raab
Employees267
Employees267
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2007
Founded2007
Employees267
Employees267
ARDX Key Statistics
Market cap2.02B
Market cap2.02B
Price-Earnings ratio-30.24
Price-Earnings ratio-30.24
Dividend yield—
Dividend yield—
Average volume7.26M
Average volume7.26M
High today$9.13
High today$9.13
Low today$7.83
Low today$7.83
Open price$8.35
Open price$8.35
Volume24.97M
Volume24.97M
52 Week high$10.13
52 Week high$10.13
52 Week low$3.16
52 Week low$3.16
ARDX News
TipRanks 1d
Ardelyx reports Q1 EPS (11c), consensus (15c)Reports Q1 revenue $46.0M, consensus $36.4M. As of March 31, 2024, the company had total cash, cash equivalents and short-term investments of $202.6 million, as...
TipRanks 2d
Ardelyx options imply 11.7% move in share price post-earningsPre-earnings options volume in Ardelyx is 1.8x normal with calls leading puts 4:1. Implied volatility suggests the market is anticipating a move near 11.7%, or...
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%